Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2018 Sep 19;362:k3783.
doi: 10.1136/bmj.k3783.

Diagnostic Expansion in Clinical Trials: Myocardial Infarction, Stroke, Cancer Recurrence, and Metastases May Not Be the Hard Endpoints You Thought They Were

Affiliations
Randomized Controlled Trial

Diagnostic Expansion in Clinical Trials: Myocardial Infarction, Stroke, Cancer Recurrence, and Metastases May Not Be the Hard Endpoints You Thought They Were

Go Nishikawa et al. BMJ. .

Conflict of interest statement

Contributors and sources: GN and VP have an interest in evidence based medicine and outcome adjudication. VP has published many articles on trial methods and evidence. They have worked together on this and several papers. Competing interests: We have read and understood BMJ policy on declaration of interests and declare that VP is funded by the Laura and John Arnold Foundation and receives royalties for his book Ending Medical Reversal. VP has received honorariums for lectures to universities, non-profit medical centres, non-profit groups, and professional societies. VP is a writer for Medscape.

Similar articles

See all similar articles

Cited by 1 article

Publication types

MeSH terms

LinkOut - more resources

Feedback